Clinical Trial

Trial Protocol ID F8294-201b *RIT*

Trial Description

A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Fore Biotherapeutics

ClinicalTrials.gov NCT ID

  • NCT05503797